# FDA OTHER_CORRESPONDENCE - Unknown Company - February 14, 2019

Source: https://www.globalkeysolutions.net/records/other_correspondence/unknown-company/fe3cbfae-2a82-40c7-bdc9-b0fdc02052b6

> FDA OTHER_CORRESPONDENCE for Unknown Company on February 14, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: OTHER_CORRESPONDENCE
- Inspection Date: 2019-02-14
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [483_RESPONSE - 2016-01-29](https://www.globalkeysolutions.net/records/483_response/unknown-company/9c3d9cb6-5c40-4b6e-8583-a79cdb64f346)
- [OTHER_CORRESPONDENCE - 2015-07-24](https://www.globalkeysolutions.net/records/other_correspondence/unknown-company/0eceeb47-3712-4b94-999b-8ac2f77435c9)
- [RESUME - Unknown Date](https://www.globalkeysolutions.net/records/resume/unknown-company/3362a8d9-3527-4b16-b028-a7a9b5d63941)
- [RESUME - Unknown Date](https://www.globalkeysolutions.net/records/resume/unknown-company/2e526b9d-c43a-4d0b-84be-03a886b460ba)
- [483_RESPONSE - 2014-06-27](https://www.globalkeysolutions.net/records/483_response/unknown-company/40dcf4d8-d200-4750-8415-263f517dfaed)

## Related Officers

- [Matthew J. Buderer](https://www.globalkeysolutions.net/people/matthew-j-buderer/10d81d0a-0e47-44d5-ab96-f1743c501ad1)
- [Katie Stabi](https://www.globalkeysolutions.net/people/katie-stabi/1bad7711-a5e1-45a7-a6fd-73b12b70799e)
- [Alvin Budeaer](https://www.globalkeysolutions.net/people/alvin-budeaer/2d05e484-887c-4a84-9e35-1f0da147d443)
- [Henry Enkelman](https://www.globalkeysolutions.net/people/henry-enkelman/2f39f529-b44c-4dc9-bed9-040a3c443f9c)
- [Kenneth E. Crawford III](https://www.globalkeysolutions.net/people/kenneth-e-crawford-iii/55b336d8-7094-49d3-8ae0-f8edfe9423c0)

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02